Akebia Therapeutics to Report Second Quarter 2025 Financial Results and Discuss Recent Business Highlights

Rhea-AI Summary

Akebia Therapeutics (Nasdaq: AKBA) has scheduled the release of its second quarter 2025 financial results for Thursday, August 7, 2025, before market open. The company will host a conference call at 8:00 a.m. EDT on the same day to discuss the results and recent business developments.

Participants are encouraged to register in advance and join the call 15 minutes early to ensure timely connection. The presentation will be accessible via live webcast through Akebia's investor relations website, with an archived version available for later viewing.

Akebia to Host Conference Call on August 7, 2025, at 8:00 a.m. EDT

CAMBRIDGE, Mass., July 31, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics^®, Inc. (Nasdaq: AKBA) today announced plans to release its financial results for the second quarter ended June 30, 2025, on Thursday, August 7, 2025, prior to the open of financial markets.

Akebia will host a conference call on Thursday, August 7, 2025, at 8:00 a.m. EDT to discuss its financial results and recent business highlights. To access the call, please register by clicking on this Registration Link, and you will be provided with dial in details. To avoid delays and ensure timely connection, we encourage dialing into the conference call 15 minutes ahead of the scheduled start time.

A live webcast of the conference call will be available via the Investors section of Akebia’s website at: https://ir.akebia.com/. An online archive of the webcast can be accessed via the Investors section of Akebia’s website at http://ir.akebia.com.

About Akebia Therapeutics
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at www.akebia.com, which does not form a part of this release.

Akebia Therapeutics Contact
Mercedes Carrasco
mcarrasco@akebia.com

FAQ

When will Akebia Therapeutics (AKBA) report Q2 2025 earnings?

Akebia Therapeutics will release its Q2 2025 financial results on Thursday, August 7, 2025, before the financial markets open.

What time is Akebia's Q2 2025 earnings conference call?

Akebia's Q2 2025 earnings conference call is scheduled for 8:00 a.m. EDT on Thursday, August 7, 2025.

How can investors access Akebia's Q2 2025 earnings call?

Investors can access the call by registering through the provided Registration Link, and a live webcast will be available through the Investors section of Akebia's website at ir.akebia.com.

Where can I find the replay of Akebia's Q2 2025 earnings call?

An archived version of the webcast will be accessible through the Investors section of Akebia's website at ir.akebia.com.